ID: ALA171673

Max Phase: Preclinical

Molecular Formula: C9H10N2O

Molecular Weight: 162.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOc1ccc2[nH]cnc2c1

Standard InChI:  InChI=1S/C9H10N2O/c1-2-12-7-3-4-8-9(5-7)11-6-10-8/h3-6H,2H2,1H3,(H,10,11)

Standard InChI Key:  SANFZVXZFRQJOL-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 2B1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 162.19Molecular Weight (Monoisotopic): 162.0793AlogP: 1.96#Rotatable Bonds: 2
Polar Surface Area: 37.91Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.57CX Basic pKa: 6.24CX LogP: 1.46CX LogD: 1.43
Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.73Np Likeness Score: -1.50

References

1. Murray M, Ryan AJ, Little PJ..  (1982)  Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationships.,  25  (8): [PMID:7120277] [10.1021/jm00350a002]

Source